These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23351020)

  • 1. Dichotomy of decorin activity on the insulin-like growth factor-I system.
    Morrione A; Neill T; Iozzo RV
    FEBS J; 2013 May; 280(10):2138-49. PubMed ID: 23351020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.
    Iozzo RV; Buraschi S; Genua M; Xu SQ; Solomides CC; Peiper SC; Gomella LG; Owens RC; Morrione A
    J Biol Chem; 2011 Oct; 286(40):34712-21. PubMed ID: 21840990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin differentially modulates the activity of insulin receptor isoform A ligands.
    Morcavallo A; Buraschi S; Xu SQ; Belfiore A; Schaefer L; Iozzo RV; Morrione A
    Matrix Biol; 2014 Apr; 35():82-90. PubMed ID: 24389353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorin inhibits the insulin-like growth factor I signaling in bone marrow mesenchymal stem cells of aged humans.
    Wong TH; Chen TY; Tseng KY; Chen ZY; Chen CH; Lin FH; Wu HM; Lin S
    Aging (Albany NY); 2020 Nov; 13(1):578-597. PubMed ID: 33257596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorin, a novel player in the insulin-like growth factor system.
    Schönherr E; Sunderkötter C; Iozzo RV; Schaefer L
    J Biol Chem; 2005 Apr; 280(16):15767-72. PubMed ID: 15701628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.
    Genua M; Xu SQ; Buraschi S; Peiper SC; Gomella LG; Belfiore A; Iozzo RV; Morrione A
    PLoS One; 2012; 7(6):e40148. PubMed ID: 22859931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.
    Metalli D; Lovat F; Tripodi F; Genua M; Xu SQ; Spinelli M; Alberghina L; Vanoni M; Baffa R; Gomella LG; Iozzo RV; Morrione A
    Am J Pathol; 2010 Jun; 176(6):2997-3006. PubMed ID: 20395438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.
    Li M; Yin Y; Hua H; Sun X; Luo T; Wang J; Jiang Y
    J Biol Chem; 2010 Oct; 285(40):30480-8. PubMed ID: 20670935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.
    Molhoek KR; Shada AL; Smolkin M; Chowbina S; Papin J; Brautigan DL; Slingluff CL
    Melanoma Res; 2011 Aug; 21(4):274-84. PubMed ID: 21654344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 Upregulates Biglycan and Decorin by Increasing Translation and Reducing ADAMTS5 Expression.
    Lee H; Lim J; Oh JH; Cho S; Chung JH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells.
    El-Shewy HM; Lee MH; Obeid LM; Jaffa AA; Luttrell LM
    J Biol Chem; 2007 Sep; 282(36):26150-7. PubMed ID: 17620336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.
    Cao L; Yu Y; Darko I; Currier D; Mayeenuddin LH; Wan X; Khanna C; Helman LJ
    Cancer Res; 2008 Oct; 68(19):8039-48. PubMed ID: 18829562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.
    Baghy K; Horváth Z; Regős E; Kiss K; Schaff Z; Iozzo RV; Kovalszky I
    FEBS J; 2013 May; 280(10):2150-64. PubMed ID: 23448253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.
    Ganguly S; Basu B; Shome S; Jadhav T; Roy S; Majumdar J; Dasgupta PS; Basu S
    Am J Pathol; 2010 Dec; 177(6):2701-7. PubMed ID: 21075859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-10,cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells.
    Jung JI; Cho HJ; Kim J; Kwon DY; Park JH
    J Med Food; 2010 Feb; 13(1):13-9. PubMed ID: 20136431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.